Clinical trial
Gemcitabine With Curcumin for Pancreatic Cancer
NCT00192842 · Rambam Health Care Campus, Other · Completed
Key facts
| NCT number | NCT00192842 |
|---|---|
| Title | Gemcitabine With Curcumin for Pancreatic Cancer |
| Official title | Phase II Trial of Gemcitabine and Curcumin in Patients With Advanced Pancreatic Cancer |
| Lead sponsor | Rambam Health Care Campus, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Drug |
| Interventions | curcumin (+ gemcitabine) |
| Enrollment | 17 |
| Start date | Jul 1, 2004 |
| Primary completion | Nov 1, 2007 |
| Completion | Sep 1, 2010 |
| First posted | Sep 19, 2005 |
| Last update posted | Sep 22, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: